Development of a loop-mediated isothermal amplification coupled lateral flow dipstick targeting erm(41) for detection of Mycobacterium abscessus and Mycobacterium massiliense

AMB Express

Table 3 Results of drug susceptibility testing against M. abscessus and M. massiliense

Drugs	Species	No. (%) of strains			χ²	P value
Drugs	Species	Susceptible	Intermediate	Resistant	χ²	P value
Clarithromycin_3d	M. abscessus	49 (94.2)	1 (1.9)	2 (3.8)	1.010	0.60
Clarithromycin_3d	M. massiliense	51 (96.2)	0 (0.0)	2 (3.8)
Clarithromycin_14d	M. abscessus	9 (17.3)	0 (0.0)	43 (82.7)	65.847	< 0.001
Clarithromycin_14d	M. massiliense	51 (96.2)	0 (0.0)	2 (3.8)
Azithromycin	M. abscessus	51 (98.1)	–	1 (1.9)	0.000	1.00
Azithromycin	M. massiliense	52 (98.1)	–	1 (1.9)
Amikacin	M. abscessus	52 (100.0)	0 (0.0)	0 (0.0)	16.178	< 0.001
Amikacin	M. massiliense	39 (73.6)	12 (22.6)	2 (3.8)
Levofloxacin	M. abscessus	0 (0.0)	0 (0.0)	52 (100.0)	0.000	1.00
Levofloxacin	M. massiliense	0 (0.0)	0 (0.0)	53 (100.0)
Moxifloxacin	M. abscessus	0 (0.0)	5 (9.6)	47 (90.4)	0.542	0.72
Moxifloxacin	M. massiliense	0 (0.0)	3 (5.7)	50 (94.3)
Gatifloxacin	M. abscessus	0 (0.0)	7 (13.5)	45 (86.5)	1.770	0.32
Gatifloxacin	M. massiliense	0 (0.0)	3 (5.7)	50 (94.3)